NCT00720408View on ClinicalTrials.gov

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Liver TransplantationTransplantation ImmunologyHost vs Graft Reaction
Interventions
DRUG

Prograf-XL

oral

DRUG

Prograf

oral

DRUG

MMF

oral

Trial Locations (4)

100

Taipei

112

Taipei

333

Taoyuan District

833

Kaohsiung City

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Taiwan, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY